
Clinical value of 18F-FDG PET/CT in evaluation of hepatic vein, inferior vena cava and right atrium tumor thrombi in hepatocellular carcinoma: Initial results
In this paper, eleven consecutive hepatocellular carcinoma (HCC) patients with an embolus in the hepatic vein (HV), inferior vena cava (IVC)and right atrium (RA) were studied with 18F-FDG PET/CT and contrast enhanced CT. When correlated with final diagnosis, 18F-FDG PET/CT and contrast enhanced CT was positive in 11 patients (100%), 7 patients (63.6%), respectively. The accuracy of PET/CT and contrast-enhanced CT were 100%, 63.6%. Three cases with secondary blood thrombi in the distant IVC, which were confirmed by PET/CT, cannot be identified by contrast enhanced CT. The average survival was 3 months (range, 1-12mo). The 12 months survival rate was 9.1%. Our results suggest that highly metabolic tumor thrombus in the HV, IVC and RA may be depicted on 18F-FDG PET/CT in HCC patients. It may discriminate between malignant and secondary benign blood thrombi.